Haili Biotech shareholder stake shift nears 1% threshold

Shanghai Hile Bio-Technology (SSE:603718) announced that shareholders Fang Wenyan and Fang Zhangle, acting in concert, have seen their combined stake in the company shift, triggering a disclosure due to crossing the 1% threshold. The change results from Fang Zhangle reducing his individual holding from 3.22% to 2.49%. Consequently, the combined stake of Fang Wenyan and Fang Zhangle now stands at 6.61%, down from 7.34%. The transaction involved Fang Zhangle selling 4,821,644 shares of RMB-denominated ordinary shares (A shares) via block trade on April 22, 2025. Haili Biotech emphasizes that this equity change will not alter the company's controlling shareholder or actual controller.